- Hardcover: 512 pages
- Publisher: Juggernaut (10 July 2019)
- Language: English
- ISBN-10: 9353450446
- ISBN-13: 978-9353450441
- Product Dimensions: 24 x 3.4 x 16.8 cm
- Customer Reviews: 57 customer reviews
- Amazon Bestsellers Rank: #989 in Books (See Top 100 in Books)
Bottle of Lies : Ranbaxy and the Dark Side of Indian Pharma Hardcover – 10 Jul 2019
Save Extra with 1 offer
- No Cost EMI : On Bajaj Finserv EMI cards if you checkout only with this item. Here's how
Frequently bought together
Customers who viewed this item also viewed
About the Author
Katherine Eban, an investigative journalist, is a Fortune magazine contributor and Andrew Carnegie fellow. She has also written for Vanity Fair, the New York Times, Self, The Nation, the New York Observer, and other publications. She is the author of Dangerous Doses: A True Story of Cops, Counterfeiters, and the Contamination of America’s Drug Supply, and lectures frequently on the topic of pharmaceutical integrity. Educated at Brown University and Oxford, where she was a Rhodes scholar, she lives in New York City with her husband and two daughters.
Enter your mobile number or email address below and we'll send you a link to download the free Kindle App. Then you can start reading Kindle books on your smartphone, tablet, or computer - no Kindle device required.
To get the free app, enter mobile phone number.
Customers who bought this item also bought
Review this product
57 customer reviews
There was a problem filtering reviews right now. Please try again later.
While one always wants to believe that Indian companies would never sell substandard products in India, this books makes me think... why not? If they don't have any ethical bone to stop from doctoring every kind of documentation to skirt the rules for profits., what is stopping them to do the same in Indian market... Indian FDA!
Well researched and told, this is a must read for every Indian.
Ranbaxy was a revered brand in my childhood. Sad to realize how many people and families accross nations were directly and indirectly impacted because of the malpractices and continue to be impacted. Not just in India but the big shot companies in US are also not squeaky clean. Reading about all the generic companies in India was an eye opener. This book literally shook my core. I dont know what to trust anymore. If you have a sick person in your family who consumes lots of medicines after reading this book you will be constantly worried about their health and the side effects of medicines consumed.
I have read better books... I have read sadder stories but this is the first book which made me cry inconsolably. Maybe because my mother has been dependent on medicines for too long and the book struck a personal cord. Guess I would never know if my mother is not recovering because of ill suited low quality contaminated medicines. My questions will remain unanswered. Ohh the lies we have been fed. Is there any hope for tomorrow? Is there a way out? When no company can be trusted what should we consume?
a good book exposing the lies of Ranbaxy and a few other
Pharma companies.It takes two for a tango! The FDA's part
Is equally shoddy.It is seen as inefficient or corrupt or both.
It took a whistle blower from India to unearth all the lies at
Ranbaxy.Not creditable enough for FDA.And people consider
it to be a gold standard.That the promoters of Ranbaxy could
cheat FDA and Daiichi Sankyo and still go scot free and now
living a life of luxury makes one's blood boil! The cover of the
book should read as " the dark side of Ranbaxy and FDA".
Both are guilty.A good read and it certainly puts a fear of
taking cheap generic drugs.
The situation was no different in USA, where branded drugs, were prohibitively expensive. The Hatch-Waxman act of 1984 was a landmark legislation that enabled low cost, high quality generic drugs, that brought healthcare closer to humanity. Till this point, I too was a champion of generic drugs, till I read this book.
What if the low-cost generics are also low in quality? What if these drugs lack efficacy and are ineffective in curing the disease? What if the drugs contain impurities that are hazardous? What if these drugs are counterproductive, and result in patient deaths? What if poorer countries that have higher need for life saving drugs are shipped the worst quality of drugs? A nightmare indeed, even if a fraction of this is true.
Now, what if these substandard drugs are manufactured in India, our homeland and exported worldwide. Personally, I felt ashamed and simultaneously angry, after reading page after page of unscrupulous factories of fraud, run by unscrupulous owners and managers, who profiteer at the expense of global health, and national pride. This book not only open our eyes, but gives sleepless nights, with a gripping narrative of what ails the generic pharma industry in India.
This book brings out company wide cultures of cheating, that is mentioned as ‘Indian Culture’ and ‘Jugaad’. Frauds are often cases of individuals gone astray. But here we find entire companies, in collusion with the regulators and bureaucracy. It appears to be a disease that has eaten into the entire system. ‘Everyone does it’ is a common excuse that we often hear from those who willfully violate the law. In addition, the culture of meek deference to those in authority, with fear of reprisal, isolation and even threat to personal safety keeps prospective whistle-blowers at bay. Hence, the ‘Chalta hai’ attitude becomes ubiquitous and keeps thriving profitably.
What is also shocking is that the FDA of United States, is not only seemingly understaffed and overloaded to stop this menace through stricter surveillance, but here too, the collusion between capitalists, politicians and bureaucracy renders it a paper tiger in most cases. The agency is under pressure to approve generics to avoid shortages. Evidence suggests that there were more than 100 cases of dilution of inspection reports from a stricter OAI (Official Action Initiated) to VAI (Voluntary Action Initiated) by FDA. So much about concern for patient safety at the agency meant to be the custodian of the law.
When India has embarked on a new phase of economic transformation and growth through ambitious initiatives like Make in India, this book comes as a shocker. Even if the contents of the book are not entirely true, it is safe to assume that the situation needs to be addressed at the highest level in Government with a strong political will to enact appropriate legislations to crack down on malpractices, protect and reward whistle blowers and usher in world class processes. Let us work to make India great again.
What stands out in this book is relentless pursuit of truth, the courage of conviction, flawless character and endurance under severe stress, of whistle blower Dinesh Thakur. At the USFDA, Peter Baker and Debbie Robertson stand tall with thorough professionalism and immaculate standards that uphold the core values of the organization they work for. It is these men and women who make a big difference, even at the cost of great personal sacrifice and challenges. The honest are few and far between. They always stand alone. But when history is written, humanity stands in salute with gratitude for their sacrifices, even if they are unnamed and unsung. Satyameva Jayate. JAI HIND.